EUCTR2008-005237-30-NL
Active, not recruiting
Not Applicable
A Multicenter, Prospective, Long-term Registry of Pediatric Patients with Crohn's Disease or Ulcerative Colitis - DEVELOP
DrugsRemicade
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Janssen Biologics B.V.
- Enrollment
- 6000
- Status
- Active, not recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Have a confirmed diagnosis of CD for at least 2 months.
- •2\. Are male or female at least 6 years of age, but less than 17 years of age with the exception of patients who participated in the Sponsor's protocol C0168T72 or C0168T62\. These patients are eligible for enrollment regardless of the patients age at the time of enrollment
- •3\. The parent/legal guardian must be capable of providing written
- •informed consent, and assent should be obtained from the child according to local regulations (age at which assent is given may vary by the IRB or EC).
- •4\. The patient's physician expects the patient to be scheduled for a
- •medical encounter (and/or other direct contact) at least every 6 months, as part of their usual care, at the time of enrollment.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 6000
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
Exclusion Criteria
- •Patients meeting any of the following criteria may not be enrolled in the
- •1\. Are less than 6 years of age or 17 years of age or older with the exception of patients who participated in the Sponsor's protocol C0168T72 or C0168T62\. These patients are eligible for enrollment regardless of the patients age at the time of enrollment
- •2\. The patient and parent/guardian are not able to adhere to the
- •protocol requirements.
- •3\. Have other Crohn's\-like diseases that are associated with genetic
- •diseases (eg, glycogen storage disease).
- •4\. Are participating in any clinical trial for an investigational agent that
- •is not commercially available.
- •5\. Are currently participating in one of the Sponsor's trials for pediatric IBD.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A Multicenter, Prospective, Long-term Registry of children with Crohn's DiseasePediatric patients with a confirmed diagnosis of CD aged 6 years to lessthan 17 years of age at the time of enrollmentMedDRA version: 14.0Level: LLTClassification code 10013099Term: Disease CrohnsSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2008-005237-30-SEJanssen Biologics BV4,000
Recruiting
Phase 4
A Multicenter, Prospective, Long-term Registry of Pediatric Patients with Crohn*s Disease and Ulcerative ColitisCrohn's diseaseUlcerative Colitis10017969NL-OMON41540Janssen Biologics BV200
Recruiting
Not Applicable
A multi-center and non-interventional registry of Brentuximab Vedotin in patients with relapsed or refractory anaplastic large cell lymphoma or classical Hodgkin lymphomaKCT0003789Samsung Medical Center150
Recruiting
Not Applicable
A multi center and non interventional registry of Korean Medicine Treatment for Patients with Shoulder pain.KCT0007128Kyung Hee University Oriental Medicine Hospital at Gangdong400
Recruiting
Not Applicable
Metastatic ColoRectal cancer India RegistryHealth Condition 1: C189- Malignant neoplasm of colon, unspecifiedCTRI/2022/07/043968Dr Reddys Laboratories